IL18 and depressive symptom measurement: It has been shown that IL-1β and IL-18 released upon the activation of NLRP3 inflammatory vesicles may be key molecules in triggering the immune response in depression and further exacerbate the pathological process through Gasdermin D (GSDMD)-mediated cellular pyroptosis response [102].